Evidence map›Paper›PMID 35618700›Full record

ArticleNature communications2022

Depletion of skeletal muscle satellite cells attenuates pathology in muscular dystrophy.

Justin G Boyer, Jiuzhou Huo, Sarah Han, Julian R Havens, Vikram Prasad, Brian L Lin, David A Kass, Taejeong Song, Sakthivel Sadayappan, Ramzi J Khairallah and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Development of an anti-CDH15/M-cadherin monoclonal antibody CaBiochemistry and biophysics reports · 2025
    Article
  7. Making sense of MYC in skeletal muscle: location, duration, and magnitude.American journal of physiology. Cell physiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Justin G BoyerDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Jiuzhou HuoDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Sarah HanDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.ORCID 0000-0003-2817-8030
Julian R HavensDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Vikram PrasadDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Brian L LinDivision of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD, 21205, USA.ORCID 0000-0003-0800-7103
David A KassDivision of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD, 21205, USA.ORCID 0000-0003-1596-2299
Taejeong SongDivision of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
Sakthivel SadayappanDivision of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.ORCID 0000-0003-2006-7678
Ramzi J KhairallahMyologica, LLC, New Market, MD, 21774, USA.
Christopher W WardDepartment of Orthopedics and Center for Biomedical Engineering and Technology (BioMET), University of Maryland School of Medicine, Baltimore, MD, USA.
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. jeff.molkentin@cchmc.org.ORCID 0000-0002-3558-6529
Cincinnati Children's Hospital Medical Center · USJohns Hopkins University · USUniversity of Cincinnati · USChromoLogic (United States) · USUniversity of Maryland, Baltimore · US

Funding

Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial DiseaseR35HL135827 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI KASS, DAVID ALAN · 2017 to 2023
$6.3M
Microtubule Regulated Mechanotransduction in Skeletal MuscleR01AR071618 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI WARD, CHRISTOPHER WILLIAM · 2017 to 2021
$2.6M
In vivo role of the fibroblast in muscular dystrophy-RenewalR01AR071301 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Jeffery D Molkentin, Davy Vanhoutte · 2018 to 2026
$2.4M
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular DystrophyUH3TR003271 · NCATS · JOHNS HOPKINS UNIVERSITY · PI KASS, DAVID ALAN, KIM, DEOK-HO · 2022 to 2024
$2.4M
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular DystrophyUG3TR003271 · NCATS · JOHNS HOPKINS UNIVERSITY · PI KASS, DAVID ALAN, KIM, DEOK-HO · 2020 to 2021
$1.6M
NCATS NIH HHS UG3 TR003271NCATS NIH HHS UH3 TR003271NHLBI NIH HHS R35 HL135827NIAMS NIH HHS R01 AR071301NIAMS NIH HHS R01 AR071618
6 · The paper itself

Abstract

Skeletal muscle can repair and regenerate due to resident stem cells known as satellite cells. The muscular dystrophies are progressive muscle wasting diseases underscored by chronic muscle damage that is continually repaired by satellite cell-driven regeneration. Here we generate a genetic strategy to mediate satellite cell ablation in dystrophic mouse models to investigate how satellite cells impact disease trajectory. Unexpectedly, we observe that depletion of satellite cells reduces dystrophic disease features, with improved histopathology, enhanced sarcolemmal stability and augmented muscle performance. Mechanistically, we demonstrate that satellite cells initiate expression of the myogenic transcription factor MyoD, which then induces re-expression of fetal genes in the myofibers that destabilize the sarcolemma. Indeed, MyoD re-expression in wildtype adult skeletal muscle reduces membrane stability and promotes histopathology, while MyoD inhibition in a mouse model of muscular dystrophy improved membrane stability. Taken together these observations suggest that satellite cell activation and the fetal gene program is maladaptive in chronic dystrophic skeletal muscle.

Indexed as

Muscular DystrophiesSatellite Cells, Skeletal MuscleAnimalsDisease Models, AnimalMiceMuscle DevelopmentMuscle, SkeletalStem Cells

Identifiers

PMID35618700
PMCPMC9135721
OpenAlexW4281572722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.